{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:02:22Z","timestamp":1790856142339,"version":"4.1.0"},"reference-count":106,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Polycystic Ovary Syndrome (PCOS), the ubiquitous reproductive disorder,\nhas been documented as highly prevalent (6-9%) in India. 10% of women globally are predicted\nto have the disease. The highly mutable endocrinopathy, with differential clinical criteria for\neach diagnosis of PCOS, can mask the severity of the syndrome by influencing the incidence and\noccurrence of PCOS.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Area Covered:<\/jats:title>\n<jats:p>When there is a solid theoretical hypothesis between the neuroendocrine origin\nand ovarian origin of PCOS, recent evidence supports the neuroendocrine derivation of the pathology.\nIt is considered of neuroendocrine basis \u2013 as it controls the ovarian axis and acts as a delicate\ntarget because it possesses receptors for various gonadal hormones, neurotransmitters &amp; neuropeptides.\nCan these neuroendocrine alterations, variations in central brain circuits, and neuropeptide\ndysregulation be the tie that would link the pathophysiology of the disorder, the occurrence of all\nthe 1\u02da and 2\u02da symptoms like polycystic ovaries, hyperandrogenism, obesity, insulin resistance,\netc., in PCOS?<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This review anticipates providing a comprehensive overview of how neuropeptides\nsuch as Kisspeptin, Neurokinin B, Dynorphin A, \u03b2-Endorphin, Nesfatin, Neuropeptide Y,\nPhoenixin, Leptin, Ghrelin, Orexin, and Neudesin influence PCOS, the understanding of which\nmay help to establish potential drug candidates against precise targets in these central circuits.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298665309949240822105900","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T04:33:20Z","timestamp":1727152400000},"page":"667-680","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Neuropeptide Network of Polycystic Ovary Syndrome \u2013 A Review"],"prefix":"10.2174","volume":"31","author":[{"given":"Dheepthi","family":"Jayamurali","sequence":"first","affiliation":[{"name":"Department of Physiology, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai\n600 113, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivetha","family":"Ravishankar","sequence":"additional","affiliation":[{"name":"Department of Physiology, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai\n600 113, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Manoharan","sequence":"additional","affiliation":[{"name":"Department of Physiology, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai\n600 113, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwari","family":"Parasuraman","sequence":"additional","affiliation":[{"name":"Department of Physiology, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai\n600 113, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Kameshwaran","family":"Jayashankar","sequence":"additional","affiliation":[{"name":"Department of Physiology, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai\n600 113, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1712-2369","authenticated-orcid":true,"given":"Sathya Narayanan","family":"Govindarajulu","sequence":"additional","affiliation":[{"name":"Department of Physiology, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai\n600 113, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"1","volume":"1","author":"Kabel A.","year":"2016","unstructured":"Kabel A.; Polycystic ovarian syndrome: Insights into pathogenesis, diagnosis. Pathog Pcos  2016,1(1),1-5","journal-title":"Pathog Pcos"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"Lizneva D.","year":"2016","unstructured":"Lizneva D.; Suturina L.; Walker W.; Brakta S.; Gavrilova-Jordan L.; Azziz R.; Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril  2016,106(1),6-15","journal-title":"Fertil Steril"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/2230-8210.107858","volume":"17","author":"Ramanand S.","year":"2013","unstructured":"Ramanand S.; Ghongane B.; Ramanand J.; Patwardhan M.; Ghanghas R.; Jain S.; Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab  2013,17(1),138-145","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","volume":"185","author":"Cussons A.J.","year":"2006","unstructured":"Cussons A.J.; Stuckey B.G.A.; Watts G.F.; Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives. Atherosclerosis  2006,185(2),227-239","journal-title":"Atherosclerosis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/humupd\/dmi013","volume":"11","author":"Abbott D.H.","year":"2005","unstructured":"Abbott D.H.; Barnett D.K.; Bruns C.M.; Dumesic D.A.; Androgen excess fetal programming of female reproduction: A developmental aetiology for polycystic ovary syndrome? Hum Reprod Update  2005,11(4),357-374","journal-title":"Hum Reprod Update"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2005-1494","volume":"91","author":"Vink J.M.","year":"2006","unstructured":"Vink J.M.; Sadrzadeh S.; Lambalk C.B.; Boomsma D.I.; Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab  2006,91(6),2100-2104","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bpobgyn.2016.03.006.","volume":"37","author":"Indran I.R.","year":"2016","unstructured":"Indran I.R.; Lee B.H.; Yong E.L.; Cellular and animal studies: Insights into pathophysiology and therapy of PCOS. Best Pract Res Clin Obstet Gynaecol  2016,37,12-24","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.coemr.2020.04.006","volume":"12","author":"Moolhuijsen L.M.E.","year":"2020","unstructured":"Moolhuijsen L.M.E.; Visser J.A.; AMH in PCOS: Controlling the ovary, placenta, or brain? Curr Opin Endocr Metab Res  2020,12,91-97","journal-title":"Curr Opin Endocr Metab Res"},{"key":"ref=9","first-page":"1223","volume":"26","year":"2005","unstructured":"Medical progress polycystic ovary syndrome. Endocrinol Metab Clin North Am  2005,26(4),1223-1236","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.bpobgyn.2004.05.004","volume":"18","author":"Balen A.","year":"2004","unstructured":"Balen A.; The pathophysiology of polycystic ovary syndrome: Trying to understand PCOS and its endocrinology. Best Pract Res Clin Obstet Gynaecol  2004,18(5),685-706","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"34631","DOI":"10.1074\/jbc.M104847200","volume":"276","author":"Kotani M.","year":"2001","unstructured":"Kotani M.; Detheux M.; Vandenbogaerde A.; Communi D.; Vanderwinden J.M.; Le Poul E.; Br\u00e9zillon S.; Tyldesley R.; Suarez-Huerta N.; Vandeput F.; Blanpain C.; Schiffmann S.N.; Vassart G.; Parmentier M.; The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem  2001,276(37),34631-34636","journal-title":"J Biol Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"10972","DOI":"10.1073\/pnas.1834399100","volume":"100","author":"de Roux N.","year":"2003","unstructured":"de Roux N.; Genin E.; Carel J.C.; Matsuda F.; Chaussain J.L.; Milgrom E.; Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA  2003,100(19),10972-10976","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ng.306","volume":"41","author":"Topaloglu A.K.","year":"2009","unstructured":"Topaloglu A.K.; Reimann F.; Guclu M.; Yalin A.S.; Kotan L.D.; Porter K.M.; Serin A.; Mungan N.O.; Cook J.R.; Ozbek M.N.; Imamoglu S.; Akalin N.S.; Yuksel B.; O\u2019Rahilly S.; Semple R.K.; TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet  2009,41(3),354-358","journal-title":"Nat Genet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1477-7827-8-4","volume":"8","author":"Page N.M.","year":"2010","unstructured":"Page N.M.; Neurokinin B and pre-eclampsia: A decade of discovery. Reprod Biol Endocrinol  2010,8(1),4","journal-title":"Reprod Biol Endocrinol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.peptides.2009.04.023","volume":"30","author":"Page N.M.","year":"2009","unstructured":"Page N.M.; Morrish D.W.; Weston-Bell N.J.; Differential mRNA splicing and precursor processing of neurokinin B in neuroendocrine tissues. Peptides  2009,30(8),1508-1513","journal-title":"Peptides"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1073\/pnas.76.12.6666","volume":"76","author":"Goldstein A.","year":"1979","unstructured":"Goldstein A.; Tachibana S.; Lowney L.I.; Hunkapiller M.; Hood L.; Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc Natl Acad Sci USA  1979,76(12),6666-6670","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"101705","DOI":"10.1016\/j.jchemneu.2019.101705","volume":"102","author":"Voigt C.","year":"2019","unstructured":"Voigt C.; Bennett N.; Reproductive status-dependent dynorphin and neurokinin B gene expression in female Damaraland mole-rats. J Chem Neuroanat  2019,102,101705","journal-title":"J Chem Neuroanat"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/cen.14704","volume":"97","author":"Garg A.","year":"2022","unstructured":"Garg A.; Patel B.; Abbara A.; Dhillo W.S.; Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf)  2022,97(2),156-164","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab158","volume":"162","author":"Moore A.M.","year":"2021","unstructured":"Moore A.M.; Lohr D.B.; Coolen L.M.; Lehman M.N.; Prenatal androgen exposure alters kndy neurons and their afferent network in a model of polycystic ovarian syndrome. Endocrinology  2021,162(11)","journal-title":"Endocrinology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1507\/endocrj.EJ16-0282","volume":"64","author":"Matsuzaki T.","year":"2017","unstructured":"Matsuzaki T.; Tungalagsuvd A.; Iwasa T.; Munkhzaya M.; Yanagihara R.; Tokui T.; Yano K.; Mayila Y.; Kato T.; Kuwahara A.; Matsui S.; Irahara M.; Kisspeptin mRNA expression is increased in the posterior hypothalamus in the rat model of polycystic ovary syndrome. Endocr J  2017,64(1),7-14","journal-title":"Endocr J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13048-022-01078-x","volume":"16","author":"Xu G.","year":"2023","unstructured":"Xu G.; Zhao X.; Li Z.; Hu J.; Li X.; Li J.; Chen Y.; Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) \/luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin\/neurokinin B\/dynorphin neurons in PCOS rats. J Ovarian Res  2023,16(1),15","journal-title":"J Ovarian Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1210\/en.2019-00137","volume":"160","author":"Porter D.T.","year":"2019","unstructured":"Porter D.T.; Moore A.M.; Cobern J.A.; Padmanabhan V.; Goodman R.L.; Coolen L.M.; Lehman M.N.; Prenatal testosterone exposure alters GABAergic synaptic inputs to GnRH and KNDy neurons in a sheep model of polycystic ovarian syndrome. Endocrinology  2019,160(11),2529-2542","journal-title":"Endocrinology"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12958-022-00963-w","volume":"20","author":"Okada H.","year":"2022","unstructured":"Okada H.; Kanasaki H.; Tumurbaatar T.; Tumurgan Z.; Oride A.; Kyo S.; Hyperandrogenism induces proportional changes in the expression of Kiss-1, Tac2, and DynA in hypothalamic KNDy neurons. Reprod Biol Endocrinol  2022,20(1),91","journal-title":"Reprod Biol Endocrinol"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0306-21.2021","volume":"8","author":"Gibson A.G.","year":"2021","unstructured":"Gibson A.G.; Jaime J.; Burger L.L.; Moenter S.M.; Prenatal androgen treatment does not alter the firing activity of hypothalamic arcuate kisspeptin neurons in female mice. eNeuro  2021,8(5)","journal-title":"eNeuro"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12905-022-02154-6","volume":"23","author":"Sun P.","year":"2023","unstructured":"Sun P.; Zhang Y.; Sun L.; Sun N.; Wang J.; Ma H.; Kisspeptin regulates the proliferation and apoptosis of ovary granulosa cells in polycystic ovary syndrome by modulating the PI3K\/AKT\/ERK signalling pathway. BMC Womens Health  2023,23(1),15","journal-title":"BMC Womens Health"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1515\/jpem-2021-0487","volume":"35","author":"Guzelkas I.","year":"2022","unstructured":"Guzelkas I.; Orbak Z.; Doneray H.; Ozturk N.; Sagsoz N.; Serum kisspeptin, leptin, neuropeptide Y, and neurokinin B levels in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab  2022,35(4),481-487","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"166242","DOI":"10.1016\/j.bbadis.2021.166242","volume":"1867","author":"Yuan C.","year":"2021","unstructured":"Yuan C.; Huang W.Q.; Guo J.H.; Liu X.Y.; Yang J.Z.; Chen J.J.; Wu Y.; Ruan Y.C.; Liu J.Y.; Cui Y.G.; Diao F.Y.; Chan H.C.; Involvement of kisspeptin in androgen-induced hypothalamic endoplasmic reticulum stress and its rescuing effect in PCOS rats. Biochim Biophys Acta Mol Basis Dis  2021,1867(12),166242","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1333","volume":"158","author":"Osuka S.","year":"2016","unstructured":"Osuka S.; Iwase A.; Nakahara T.; Kondo M.; Saito A.; Bayasula ; Nakamura T.; Takikawa S.; Goto M.; Kotani T.; Kikkawa F.; Kisspeptin in the hypothalamus of two rat models of polycystic ovary syndrome. Endocrinology  2016,158(2)","journal-title":"Endocrinology"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"724632","DOI":"10.3389\/fendo.2021.724632","volume":"12","author":"Uenoyama Y.","year":"2021","unstructured":"Uenoyama Y.; Nagae M.; Tsuchida H.; Inoue N.; Tsukamura H.; Role of KNDy neurons expressing kisspeptin, neurokinin B, and dynorphin A as a GnRH pulse generator controlling mammalian reproduction. Front Endocrinol (Lausanne)  2021,12(724632),724632","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1210\/en.2019-00428","volume":"160","author":"Ruddenklau A.","year":"2019","unstructured":"Ruddenklau A.; Campbell R.E.; Neuroendocrine impairments of polycystic ovary syndrome. Endocrinology  2019,160(10),2230-2242","journal-title":"Endocrinology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/258577a0","volume":"258","author":"Hughes J.","year":"1975","unstructured":"Hughes J.; Smith T.W.; Kosterlitz H.W.; Fothergill L.A.; Morgan B.A.; Morris H.R.; Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature  1975,258(5536),577-579","journal-title":"Nature"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0015-0282(16)53928-4","volume":"54","author":"Wallach E.E.","year":"1990","unstructured":"Wallach E.E.; Seifer D.B.; Collins R.L.; Current concepts of \u03b2-endorphin physiology in female reproductive dysfunction. Fertil Steril  1990,54(5),757-771","journal-title":"Fertil Steril"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fertnstert.2009.05.012","volume":"92","author":"Eyvazzadeh A.D.","year":"2009","unstructured":"Eyvazzadeh A.D.; Pennington K.P.; Pop-Busui R.; Sowers M.; Zubieta J.K.; Smith Y.R.; The role of the endogenous opioid system in polycystic ovary syndrome. Fertil Steril  2009,92(1),1-12","journal-title":"Fertil Steril"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-0035-1564094","volume":"124","author":"Kia\u0142ka M.","year":"2016","unstructured":"Kia\u0142ka M.; Milewicz T.; Spa\u0142kowska M.; Krzyczkowska-Sendrakowska M.; Wasyl B.; Pe\u0142ka A.; Krzysiek J.; \u03b2-endorphins plasma level is higher in lean Polycystic Ovary Syndrome (PCOS) Women. Exp Clin Endocrinol Diabetes  2016,124(1),55-60","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0028-2243(89)90062-2","volume":"30","author":"Nappi C.","year":"1989","unstructured":"Nappi C.; Petraglia F.; Cudemo V.; Volpe A.; Facchinetti U.; Genazzani AR.; Montemagno U.; Plasma beta-endorphin levels in obese and non-obese patients with polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol  1989,30(2),151-156","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/0002-9378(92)91781-5","volume":"167","author":"Carmina E.","year":"1992","unstructured":"Carmina E.; Ditkoff E.C.; Malizia G.; Vijod A.G.; Janni A.; Lobo R.A.; Increased circulating levels of immunoreactive \u03b2-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion. Am J Obstet Gynecol  1992,167(6),1819-1824","journal-title":"Am J Obstet Gynecol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.9734\/ARRB\/2015\/12932","volume":"5","author":"Zangeneh F.","year":"2015","unstructured":"Zangeneh F.; Naghizadeh M.; Abdollahi A.; Abedinia N.; Opioid system (\u03b2-endorphin) and stress hormones profiling in women with polycystic ovary syndrome. Annu Res Rev Biol  2015,5(5),409-418","journal-title":"Annu Res Rev Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1095\/biolreprod.103.022368","volume":"70","author":"Stener-Victorin E.","year":"2004","unstructured":"Stener-Victorin E.; Lindholm C.; Immunity and \u03b2-endorphin concentrations in hypothalamus and plasma in rats with steroid-induced polycystic ovaries: Effect of low-frequency electroacupuncture. Biol Reprod  2004,70(2),329-333","journal-title":"Biol Reprod"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1210\/en.2006-0097","volume":"147","author":"Lin E.J.D.","year":"2006","unstructured":"Lin E.J.D.; Sainsbury A.; Lee N.J.; Boey D.; Couzens M.; Enriquez R.; Slack K.; Bland R.; During M.J.; Herzog H.; Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyper- insulinemia despite persistence of hyperphagia and obesity. Endocrinology  2006,147(11),5094-5101","journal-title":"Endocrinology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5472\/marumj.500032","volume":"32","author":"Koseci T.","year":"2019","unstructured":"Koseci T.; Kaya O.; Haksoyler V.; Derici V.D.; Sezer K.; Investigation of the relationship between insulin resistance and neuropeptide Y levels in polycystic ovary syndrome. Marmara Med J  2019,32(1),1-6","journal-title":"Marmara Med J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.6136091","volume":"221","author":"Allen Y.S.","year":"1983","unstructured":"Allen Y.S.; Adrian TE.; Allen JM.; Tatemoto K.; Crow TJ.; Bloom SR.; Polak JM.; Neuropeptide Y distribution in the rat brain. Science  1983,221(4613),877-9","journal-title":"Science"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/09513599909167578","volume":"13","author":"Baranowska B.","year":"1999","unstructured":"Baranowska B.; Radzikowska M.; Wasilewska-Dziubi\u0144ska E.; Kapli\u0144ski A.; Roguski K.; P\u0142onowski A.; Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Gynecol Endocrinol  1999,13(5),344-351","journal-title":"Gynecol Endocrinol"},{"key":"ref=43","volume":"13","author":"Rosenberg S.L.","year":"2019","unstructured":"Rosenberg S.L.; The relationship between PCOS and obesity: Which comes first? Sci J Lander Coll Arts Sci  2019,13(1)","journal-title":"Sci J Lander Coll Arts Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1046\/j.1460-9568.1999.00553.x","volume":"11","author":"Parker R.M.C.","year":"1999","unstructured":"Parker R.M.C.; Herzog H.; Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci  1999,11(4),1431-1448","journal-title":"Eur J Neurosci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1210\/en.2003-0470","volume":"144","author":"Turi G.F.","year":"2003","unstructured":"Turi G.F.; Liposits Z.; Moenter S.M.; Fekete C.; Hrabovszky E.; Origin of neuropeptide Y-containing afferents to gonadotropin-releasing hormone neurons in male mice. Endocrinology  2003,144(11),4967-4974","journal-title":"Endocrinology"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1046\/j.1365-2826.2003.01087.x","volume":"15","author":"Estrada K.M.","year":"2003","unstructured":"Estrada K.M.; Pompolo S.; Morris M.J.; Tilbrook A.J.; Clarke I.J.; Neuropeptide Y (NPY) delays the oestrogen-induced luteinizing hormone (LH) surge in the ovariectomized ewe: Further evidence that NPY has a predominant negative effect on LH secretion in the ewe. J Neuroendocrinol  2003,15(11),1011-1020","journal-title":"J Neuroendocrinol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1210\/en.2012-1470","volume":"153","author":"Roa J.","year":"2012","unstructured":"Roa J.; Herbison A.E.; Direct regulation of GnRH neuron excitability by arcuate nucleus POMC and NPY neuron neuropeptides in female mice. Endocrinology  2012,153(11),5587-5599","journal-title":"Endocrinology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.yfrne.2017.07.008","volume":"48","author":"Manfredi-Lozano M.","year":"2018","unstructured":"Manfredi-Lozano M.; Roa J.; Tena-Sempere M.; Connecting metabolism and gonadal function: Novel central neuropeptide pathways involved in the metabolic control of puberty and fertility. Front Neuroendocrinol  2018,48(May),37-49","journal-title":"Front Neuroendocrinol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e0259609","DOI":"10.1371\/journal.pone.0259609","volume":"17","author":"Li Y.","year":"2022","unstructured":"Li Y.; Zhi W.; Haoxu D.; Qing W.; Ling C.; Ping Y.; Dongmei H.; Effects of electroacupuncture on the expression of hypothalamic neuropeptide Y and ghrelin in pubertal rats with polycystic ovary syndrome. PLoS One  2022,17(6),e0259609","journal-title":"PLoS One"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1159\/000521236","volume":"112","author":"Liu Y.","year":"2022","unstructured":"Liu Y.; Xu Y.C.; Cui Y.G.; Jiang S.W.; Diao F.Y.; Liu J.Y.; Ma X.; Androgen excess increases food intake in a rat polycystic ovary syndrome model by downregulating hypothalamus insulin and leptin signaling pathways preceding weight gain. Neuroendocrinology  2022,112(10),966-981","journal-title":"Neuroendocrinology"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13048-023-01261-8","volume":"16","author":"Urata Y.","year":"2023","unstructured":"Urata Y.; Salehi R.; Wyse B.A.; Jahangiri S.; Librach C.L.; Tzeng C.R.; Osuga Y.; Tsang B.; Neuropeptide Y directly reduced apoptosis of granulosa cells, and the expression of NPY and its receptors in PCOS subjects. J Ovarian Res  2023,16(1),182","journal-title":"J Ovarian Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1365-2265.2008.03204.x","volume":"69","author":"Romualdi D.","year":"2008","unstructured":"Romualdi D.; De Marinis L.; Campagna G.; Proto C.; Lanzone A.; Guido M.; Alteration of ghrelin\u2013neuropeptide Y network in obese patients with polycystic ovary syndrome: Role of hyperinsulinism. Clin Endocrinol (Oxf)  2008,69(4),562-567","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s42000-023-00460-8","volume":"22","author":"Chen WH.","year":"2023","unstructured":"Chen WH.; Shi YC.; Huang QY.; Chen JM.; Wang ZY.; Lin S.; Shi QY.; Potential for NPY receptor-related therapies for polycystic ovary syndrome: An updated review. Hormones (Athens)  2023,22(3),441-451","journal-title":"Hormones (Athens)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/09513590.2017.1290068","volume":"33","author":"Xu Y.","year":"2017","unstructured":"Xu Y.; Zhang H.; Li Q.; Lao K.; Wang Y.; The role of nesfatin-1 expression in letrozole-induced polycystic ovaries in the rat. Gynecol Endocrinol  2017,33(6),438-441","journal-title":"Gynecol Endocrinol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cca.2021.08.005","volume":"522","author":"Luo J.","year":"2021","unstructured":"Luo J.; Wen F.; Qiu D.; Wang S.; Nesfatin-1 in lipid metabolism and lipid-related diseases. Clin Chim Acta  2021,522,23-30","journal-title":"Clin Chim Acta"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12020-013-9923-0","volume":"44","author":"Aydin S.","year":"2013","unstructured":"Aydin S.; Multi-functional peptide hormone NUCB2\/nesfatin-1. Endocrine  2013,44(2),312-325","journal-title":"Endocrine"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5923\/j.diabetes.20190801.03.","volume":"8","author":"Rezk M.Y.","year":"2019","unstructured":"Rezk M.Y.; Elkatawy H.A.; Fouad R.A.; Enan E.T.; Attia M.A.; Nesfatin-1: A potential therapeutic target in a rat model of polycystic ovary syndrome. Int J Diabetes Res  2019,8(1),9-16","journal-title":"Int J Diabetes Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s12020-012-9638-7","volume":"42","author":"Deniz R.","year":"2012","unstructured":"Deniz R.; Gurates B.; Aydin S.; Celik H.; Sahin \u0130.; Baykus Y.; Catak Z.; Aksoy A.; Citil C.; Gungor S.; Nesfatin-1 and other hormone alterations in polycystic ovary syndrome. Endocrine  2012,42(3),694-699","journal-title":"Endocrine"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nature05162","volume":"443","author":"Oh-I S.","year":"2006","unstructured":"Oh-I S.; Shimizu H.; Satoh T.; Okada S.; Adachi S.; Inoue K.; Eguchi H.; Yamamoto M.; Imaki T.; Hashimoto K.; Tsuchiya T.; Monden T.; Horiguchi K.; Yamada M.; Mori M.; Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature  2006,443(7112),709-12","journal-title":"Nature"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40618-014-0089-2","volume":"37","author":"Ademoglu E.N.","year":"2014","unstructured":"Ademoglu E.N.; Gorar S.; Carl\u0131oglu A.; Yaz\u0131c\u0131 H.; Dellal F.D.; Berberoglu Z.; Akdeniz D.; Uysal S.; Karakurt F.; Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome. J Endocrinol Invest  2014,37(8),715-719","journal-title":"J Endocrinol Invest"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.18203\/2320-1770.ijrcog20230128","volume":"12","author":"Fatima F.","year":"2023","unstructured":"Fatima F.; Saxena P.; Jain A.; Correlation of serum Nesfatin 1 level with metabolic and clinical parameters in Indian women with and without polycystic ovarian syndrome. Int J Reprod Contracept Obstet Gynecol  2023,12(2),427-431","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3109\/09513590.2015.1024219","volume":"31","author":"Alp E.","year":"2015","unstructured":"Alp E.; G\u00f6rm\u00fc\u015f U.; G\u00fcd\u00fcc\u00fc N.; Bozkurt S.; Nesfatin-1 levels and metabolic markers in polycystic ovary syndrome. Gynecol Endocrinol  2015,31(7),543-547","journal-title":"Gynecol Endocrinol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1530\/endoabs.35.P620","volume":"30","author":"Binneto\u01e7lu E.","year":"2014","unstructured":"Binneto\u01e7lu E.; Erbag G.; Gencer M.; Turkon H.; Asik M.; Gunes F.; Sen H.; Vural A.; Ukinc K.; Plasma levels of nesfatin-1 in patients with polycystic ovary syndrome. Endocrine Abstracts  2014,30(1),201-204","journal-title":"Endocrine Abstracts"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.rbmo.2017.03.023","volume":"35","author":"Nylander M.","year":"2017","unstructured":"Nylander M.; Fr\u00f8ssing S.; Clausen H.V.; Kistorp C.; Faber J.; Skouby S.O.; Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial. Reprod Biomed Online  2017,35(1),121-127","journal-title":"Reprod Biomed Online"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cca.2017.06.013","volume":"471","author":"Ullah K.","year":"2017","unstructured":"Ullah K.; ur Rahman T.; Wu D.D.; Lin X.H.; Liu Y.; Guo X.Y.; Leung P.C.K.; Zhang R.J.; Huang H.F.; Sheng J.Z.; Phoenixin-14 concentrations are increased in association with luteinizing hormone and nesfatin-1 concentrations in women with polycystic ovary syndrome. Clin Chim Acta  2017,471,243-247","journal-title":"Clin Chim Acta"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.bbrc.2020.05.101","volume":"528","author":"Kalamon N.","year":"2020","unstructured":"Kalamon N.; B\u0142aszczyk K.; Szlaga A.; Billert M.; Skrzypski M.; Pawlicki P.; G\u00f3rowska - W\u00f3jtowicz E.; Kotula - Balak M.; B\u0142asiak A.; Rak A.; Levels of the neuropeptide phoenixin-14 and its receptor GRP173 in the hypothalamus, ovary and periovarian adipose tissue in rat model of polycystic ovary syndrome. Biochem Biophys Res Commun  2020,528(4),628-635","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"585887","DOI":"10.3389\/fendo.2021.585887","volume":"12","author":"Obradovic M.","year":"2021","unstructured":"Obradovic M.; Sudar-Milovanovic E.; Soskic S.; Essack M.; Arya S.; Stewart A.J.; Gojobori T.; Isenovic E.R.; Leptin and obesity: Role and clinical implication. Front Endocrinol (Lausanne)  2021,12(May),585887","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"600","DOI":"10.25122\/jml-2021-0153","volume":"14","author":"Akeel Al-hussaniy H.","year":"2021","unstructured":"Akeel Al-hussaniy H.; Hikmate A.A.; Akeel N.M.; Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions. J Med Life  2021,14(5),600-605","journal-title":"J Med Life"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2147\/DMSO.S182406","volume":"12","author":"Gruzdeva O.","year":"2019","unstructured":"Gruzdeva O.; Borodkina D.; Uchasova E.; Dyleva Y.; Barbarash O.; Leptin resistance: Underlying mechanisms and diagnosis. Diabetes Metab Syndr Obes  2019,12,191-198","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"845165","DOI":"10.3389\/fendo.2022.845165","volume":"13","author":"Peng Y.","year":"2022","unstructured":"Peng Y.; Yang H.; Song J.; Feng D.; Na Z.; Jiang H.; Meng Y.; Shi B.; Li D.; Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome. Front Endocrinol (Lausanne)  2022,13(845165),845165","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4103\/2230-8210.180005","volume":"20","author":"Jalilian N.","year":"2016","unstructured":"Jalilian N.; Haghnazari L.; Rasolinia S.; Leptin and body mass index in polycystic ovary syndrome. Indian J Endocrinol Metab  2016,20(3),324-328","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1507\/endocrj.EJ15-0318","volume":"63","author":"Gao T.","year":"2016","unstructured":"Gao T.; Wu L.; Chang F.; Cao G.; Low circulating ghrelin levels in women with polycystic ovary syndrome: A systematic review and meta-analysis. Endocr J  2016,63(1),93-100","journal-title":"Endocr J"},{"key":"ref=73","first-page":"117","volume":"6","author":"Houjeghani S.","year":"2012","unstructured":"Houjeghani S.; Pourghassem G.B.; Farzadi L.; Serum leptin and ghrelin levels in women with polycystic ovary syndrome: Correlation with anthropometric, metabolic, and endocrine parameters. Int J Fertil Steril  2012,6(2),117-126","journal-title":"Int J Fertil Steril"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s43043-019-0006-x","volume":"24","author":"Rashad N.M.","year":"2020","unstructured":"Rashad N.M.; Saraya Y.S.; Afifi S.A.; Ali A.E.; Al-sayed R.M.; Impact of weight loss on plasma ghrelin level, clinical, and metabolic features of obese women with or without polycystic ovary syndrome. Middle East Fertil Soc J  2020,24(1),12","journal-title":"Middle East Fertil Soc J"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejogrb.2010.11.019","volume":"155","author":"Daghestani M.H.","year":"2011","unstructured":"Daghestani M.H.; Daghestani M.H.; El-Mazny A.; Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features. Eur J Obstet Gynecol Reprod Biol  2011,155(1),65-68","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3109\/09513590.2012.754874","volume":"29","author":"Yilmaz E.","year":"2013","unstructured":"Yilmaz E.; Celik O.; Celik N.; Simsek Y.; Celik E.; Yildirim E.; Serum orexin-A (OXA) level decreases in polycystic ovarian syndrome. Gynecol Endocrinol  2013,29(4),388-390","journal-title":"Gynecol Endocrinol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"EP98","DOI":"10.1530\/endoabs.99.EP98","volume":"99","author":"Absatarova Y.","year":"2024","unstructured":"Absatarova Y.; Evseeva Y.; Andreeva E.; Samsonova M.; Orexin A is a new marker of insulin resistance in polycystic ovary syndrome. Endocrine Abstracts  2024,99,EP98","journal-title":"Endocrine Abstracts"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13048-023-01168-4","volume":"16","author":"Kouhetsani S.","year":"2023","unstructured":"Kouhetsani S.; Khazali H.; Rajabi-Maham H.; Orexin antagonism and substance-P: Effects and interactions on polycystic ovary syndrome in the wistar rats. J Ovarian Res  2023,16(1),89","journal-title":"J Ovarian Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2174\/138920312804142110.","volume":"13","author":"Kimura I.","year":"2012","unstructured":"Kimura I.; Nakayama Y.; Konishi M.; Terasawa K.; Ohta M.; Itoh N.; Fujimoto M.; Functions of MAPR (membrane-associated progesterone receptor) family members as heme\/steroid-binding proteins. Curr Protein Pept Sci  2012,13(7),687-696","journal-title":"Curr Protein Pept Sci"},{"key":"ref=80","first-page":"3244","volume":"3253","author":"Rodrigues T.B.","year":"2007","unstructured":"Rodrigues T.B.; Ballesteros P.; Ramirez B.G.; Violante I.R.; Cruz F.; Fonseca L.L.; Margarida M.; Castro C.A.; Garcia-Martin M.L.; Cerdan S.; Kinetic properties of the redox switch\/redox coupling mechanism as determined in primary cultures of cortical neurons and astrocytes from rat brain. J Neurosci Res  2007,3253,3244-3253","journal-title":"J Neurosci Res"},{"key":"ref=81","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2002-3-12-research0068","volume":"3","author":"Mifsud W.","year":"2002","unstructured":"Mifsud W.; Bateman A.; Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain. Genome Biol  2002,3(12)","journal-title":"Genome Biol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jnr.20356","volume":"79","author":"Kimura I.","year":"2005","unstructured":"Kimura I.; Yoshioka M.; Konishi M.; Miyake A.; Itoh N.; Neudesin, a novel secreted protein with a unique primary structure and neurotrophic activity. J Neurosci Res  2005,79(3),287-294","journal-title":"J Neurosci Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fmolb.2015.00024","volume":"2","author":"Ohta H.","year":"2015","unstructured":"Ohta H.; Kimura I.; Konishi M.; Itoh N.; Neudesin as a unique secreted protein with multi-functional roles in neural functions, energy metabolism, and tumorigenesis. Front Mol Biosci  2015,2(MAY),24","journal-title":"Front Mol Biosci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.3390\/ijerph19042099","volume":"19","author":"Kruszewska J.","year":"2022","unstructured":"Kruszewska J.; Laudy-Wiaderny H.; Kunicki M.; Review of novel potential insulin resistance biomarkers in PCOS patients\u2014the debate is still open. Int J Environ Res Public Health  2022,19(4),2099","journal-title":"Int J Environ Res Public Health"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5603\/GP.a2021.0139","volume":"93","author":"Yilmaz Y.H.","year":"2021","unstructured":"Yilmaz Y.H.; Demirpence M.; Colak A.; Zeytinli M.; Yasar E.; Taylan A.; Serum neudesin levels in patients with polycystic ovary syndrome. Ginekol Pol  2021,93(7),525-530","journal-title":"Ginekol Pol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/09513590.2020.1751106","volume":"36","author":"Bozkaya G.","year":"2020","unstructured":"Bozkaya G.; Fenercioglu O.; Demir \u0130.; Guler A.; Aslanipour B.; Calan M.; Neudesin: a neuropeptide hormone decreased in subjects with polycystic ovary syndrome. Gynecol Endocrinol  2020,36(10),849-853","journal-title":"Gynecol Endocrinol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"57","DOI":"10.17305\/bjbms.2015.432","volume":"15","author":"Kir S.F.","year":"2015","unstructured":"Kir S.F.; Baydur S.S.; Mete U.U.; Cumhur C.M.; Senturk S.; Bayoglu T.Y.; Balik G.; Cure E.; Yuce S.; Kirbas A.; Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome. Bosn J Basic Med Sci  2015,15(3),57-63","journal-title":"Bosn J Basic Med Sci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4274\/jcrpe.galenos.2021.2021.0208","volume":"14","author":"\u00c7elikkol A.","year":"2022","unstructured":"\u00c7elikkol A.; Binay C.; Ay\u00e7i\u00e7ek \u00d6.; G\u00fczel S.; Serum neudesin levels in obese adolescents. J Clin Res Pediatr Endocrinol  2022,14(1),69-75","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1172\/JCI71075","volume":"124","author":"Tolson K.P.","year":"2014","unstructured":"Tolson K.P.; Garcia C.; Yen S.; Simonds S.; Stefanidis A.; Lawrence A.; Smith J.T.; Kauffman A.S.; Impaired kisspeptin signaling decreases metabolism and promotes glucose intolerance and obesity. J Clin Invest  2014,124(7),3075-3079","journal-title":"J Clin Invest"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"Witchel S.F.","year":"2019","unstructured":"Witchel S.F.; Oberfield S.E.; Pe\u00f1a A.S.; Polycystic ovary syndrome: Pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc  2019,3(8),1545-1573","journal-title":"J Endocr Soc"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"928143","DOI":"10.3389\/fendo.2022.928143","volume":"13","author":"Mills E.G.","year":"2022","unstructured":"Mills E.G.; Yang L.; Abbara A.; Dhillo W.S.; Comninos A.N.; Current perspectives on kisspeptins role in behaviour. Front Endocrinol (Lausanne)  2022,13,928143","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1530\/RAF-20-0025","volume":"1","author":"Merkley C.M.","year":"2020","unstructured":"Merkley C.M.; Renwick A.N.; Shuping S.L.; Harlow K.; Sommer J.R.; Nestor C.C.; Undernutrition reduces kisspeptin and neurokinin B expression in castrated male sheep. Reprod Fertil  2020,1(1),21-33","journal-title":"Reprod Fertil"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"19846","DOI":"10.1073\/pnas.1211517109","volume":"109","author":"Mittelman-Smith M.A.","year":"2012","unstructured":"Mittelman-Smith M.A.; Williams H.; Krajewski-Hall S.J.; McMullen N.T.; Rance N.E.; Role for kisspeptin\/neurokinin B\/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature. Proc Natl Acad Sci USA  2012,109(48),19846-19851","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2216313","DOI":"10.1080\/09513590.2023.2216313","volume":"39","author":"Szeliga A.","year":"2023","unstructured":"Szeliga A.; Podfigurna A.; Bala G.; Meczekalski B.; Decreased neurokinin B as a risk factor of functional hypothalamic amenorrhea. Gynecol Endocrinol  2023,39(1),2216313","journal-title":"Gynecol Endocrinol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/ijms22010338","volume":"22","author":"Pilozzi A.","year":"2020","unstructured":"Pilozzi A.; Carro C.; Huang X.; Roles of \u03b2-endorphin in stress, behavior, neuroinflammation, and brain energy metabolism. Int J Mol Sci  2020,22(1),338","journal-title":"Int J Mol Sci"},{"key":"ref=96","first-page":"630","volume":"63","author":"Wortsman J.","year":"1984","unstructured":"Wortsman J.; Wehrenberg W.B.; Gavin J.R.; Allen J.P.; Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome. Obstet Gynecol  1984,63(5),630-634","journal-title":"Obstet Gynecol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00404-018-4793-6","volume":"298","author":"Jaschke N.","year":"2018","unstructured":"Jaschke N.; Lunger F.; Wildt L.; Seeber B.; Beta endorphin in serum and follicular fluid of PCOS- and non-PCOS women. Arch Gynecol Obstet  2018,298(1),217-222","journal-title":"Arch Gynecol Obstet"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-26890-9","volume":"13","author":"Guo Z.","year":"2023","unstructured":"Guo Z.; Li Y.; Prisoner's dilemma game model Based on historical strategy information. Sci Rep  2023,13(1),1","journal-title":"Sci Rep"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0028-2243(87)90158-4","volume":"24","author":"Laatikainen T.","year":"1987","unstructured":"Laatikainen T.; Salminen K.; Virtanen T.; Apter D.; Plasma \u03b2-endorphin, \u03b2-lipotropin and corticotropin in polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol  1987,24(4),327-333","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1098\/rstb.2006.1855","volume":"361","author":"Beck B.","year":"2006","unstructured":"Beck B.; Neuropeptide Y in normal eating and in genetic and dietary-induced obesity. Philos Trans R Soc Lond B Biol Sci  2006,361(1471),1159-1185","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13578-021-00657-7","volume":"11","author":"Zhang Y.","year":"2021","unstructured":"Zhang Y.; Liu C.Y.; Chen W.C.; Shi Y.C.; Wang C.M.; Lin S.; He H.F.; Regulation of neuropeptide Y in body microenvironments and its potential application in therapies: A review. Cell Biosci  2021,11(1),151","journal-title":"Cell Biosci"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"695623","DOI":"10.3389\/fcell.2021.695623","volume":"9","author":"Huang Y.","year":"2021","unstructured":"Huang Y.; Lin X.; Lin S.; Neuropeptide Y and metabolism syndrome: An update on perspectives of clinical therapeutic intervention strategies. Front Cell Dev Biol  2021,9,695623","journal-title":"Front Cell Dev Biol"},{"key":"ref=103","first-page":"4","volume":"19","author":"Ayada C.","year":"2015","unstructured":"Ayada C.; Toru \u00dc.; Korkut Y.; Nesfatin-1 and its effects on different systems. Hippokratia  2015,19(1),4-10","journal-title":"Hippokratia"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00018-012-1138-7","volume":"70","author":"Angelone T.","year":"2013","unstructured":"Angelone T.; Filice E.; Pasqua T.; Amodio N.; Galluccio M.; Montesanti G.; Quintieri A.M.; Cerra M.C.; Nesfatin-1 as a novel cardiac peptide: Identification, functional characterization, and protection against ischemia\/reperfusion injury. Cell Mol Life Sci  2013,70(3),495-509","journal-title":"Cell Mol Life Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2147\/DMSO.S193259","volume":"12","author":"Kratochvilova H.","year":"2019","unstructured":"Kratochvilova H.; Lacinova Z.; Klouckova J.; Kavalkova P.; Cinkajzlova A.; Trachta P.; Krizova J.; Benes M.; Dolezalova K.; Fried M.; Vlasakova Z.; Pelikanova T.; Spicak J.; Mraz M.; Haluzik M.; Neudesin in obesity and type 2 diabetes mellitus: The effect of acute fasting and weight reducing interventions. Diabetes Metab Syndr Obes  2019,12,423-430","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1210\/jc.2008-0115","volume":"93","author":"Elkind-Hirsch K.","year":"2008","unstructured":"Elkind-Hirsch K.; Marrioneaux O.; Bhushan M.; Vernor D.; Bhushan R.; Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab  2008,93(7),2670-2678","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665309949240822105900","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233936\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665309949240822105900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T09:42:18Z","timestamp":1733996538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233936\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":106,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665309949240822105900","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}